Details

Role Group Leader / Honorary Fellow Manager

Research area Genomic Medicine

Group Molecular Therapies

Top Publications

Fredwall, SO, Linge, J, Leinhard, OD, Kjønigsen, L, Eggesbø, HB, Weedon-Fekjær, H, Lidal, IB, Månum, G, Savarirayan, R, Tonstad, S. Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia. Genetics in Medicine 23(11) : 2234 -2234 2021
view publication
Kumble, S, Savarirayan, R. Emerging therapies for Achondroplasia: changing the rules of the game. Expert Opinion on Emerging Drugs 26(4) : 425 -431 2021
view publication
Savarirayan, R, Irving, M, Hoover-Fong, J, Bacino, CA, Ozono, K, Mohnike, K, Cormier-Daire, V, Leiva-Gea, A, Alanay, Y, Andrews, M, et al. Vosoritide treatment accelerates bone growth in children with achondroplasia. Future Rare Diseases 1(3) : frd14 2021
view publication
Savarirayan, R, Tofts, L, Irving, M, Wilcox, W, Bacino, CA, Hoover-Fong, J, Font, RU, Harmatz, P, Rutsch, F, Bober, MB, et al. Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study. Journal of the Endocrine Society 5(Supplement_1) : a670 -a671 2021
view publication
Savarirayan, R, Kannu, P, Dambkowski, CL, Rogoff, D, Irving, M. Infigratinib in Children With Achondroplasia (ACH): Design of PROPEL2 - A Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study. Journal of the Endocrine Society 5(Supplement_1) : a667 -a668 2021
view publication